相似文献
1
Protein ISGylation modulates the JAK-STAT signaling pathway.
Genes Dev. 2003 Feb 15;17(4):455-60. doi: 10.1101/gad.1056303.
2
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.
EMBO J. 2006 Jun 7;25(11):2358-67. doi: 10.1038/sj.emboj.7601149. Epub 2006 May 18.
3
Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling.
J Immunol. 2005 Jul 15;175(2):847-54. doi: 10.4049/jimmunol.175.2.847.
4
Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.
Mol Cell Biol. 2004 Nov;24(21):9592-600. doi: 10.1128/MCB.24.21.9592-9600.2004.
5
Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
Biochem J. 2000 Jul 15;349(Pt 2):427-34. doi: 10.1042/0264-6021:3490427.
6
IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Oncogene. 2000 Jul 13;19(30):3372-83. doi: 10.1038/sj.onc.1203670.
7
Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling.
Mol Cell Biol. 2006 Jan;26(2):472-9. doi: 10.1128/MCB.26.2.472-479.2006.
8
Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
J Virol. 2005 Oct;79(20):12828-39. doi: 10.1128/JVI.79.20.12828-12839.2005.
9
Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3.
J Biol Chem. 2002 Apr 26;277(17):14703-11. doi: 10.1074/jbc.M111527200. Epub 2002 Feb 19.
10
Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.
Mol Pharmacol. 2004 Mar;65(3):589-98. doi: 10.1124/mol.65.3.589.
引用本文的文献
1
The concerted actions of microRNA-29a and interferon-β modulate complete Freund's adjuvant-induced inflammatory pain by regulating the expression of type 1 interferon receptor, interferon-stimulated gene 15, and p-extracellular signal-regulated kinase.
BJA Open. 2025 Feb 3;13:100376. doi: 10.1016/j.bjao.2024.100376. eCollection 2025 Mar.
2
Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV.
Virol J. 2024 Dec 4;21(1):314. doi: 10.1186/s12985-024-02589-3.
3
Glial 'omics in ischemia: Acute stroke and chronic cerebral small vessel disease.
Glia. 2025 Mar;73(3):495-518. doi: 10.1002/glia.24634. Epub 2024 Oct 27.
4
Type I interferon regulation by USP18 is a key vulnerability in cancer.
iScience. 2024 Mar 27;27(4):109593. doi: 10.1016/j.isci.2024.109593. eCollection 2024 Apr 19.
5
Bulk and single cells transcriptomes with experimental validation identify USP18 as a novel glioma prognosis and proliferation indicator.
Exp Ther Med. 2024 Mar 26;27(5):229. doi: 10.3892/etm.2024.12517. eCollection 2024 May.
6
In the moonlight: non-catalytic functions of ubiquitin and ubiquitin-like proteases.
Front Mol Biosci. 2024 Feb 22;11:1349509. doi: 10.3389/fmolb.2024.1349509. eCollection 2024.
7
Reprogramming of tumor-associated macrophages via NEDD4-mediated CSF1R degradation by targeting USP18.
Cell Rep. 2023 Dec 26;42(12):113560. doi: 10.1016/j.celrep.2023.113560. Epub 2023 Dec 13.
8
ISGylation-independent protection of cell growth by USP18 following interferon stimulation.
Biochem J. 2023 Oct 11;480(19):1571-1581. doi: 10.1042/BCJ20230301.
9
Protein ISGylation: a posttranslational modification with implications for malignant neoplasms.
Explor Target Antitumor Ther. 2023;4(4):699-715. doi: 10.37349/etat.2023.00162. Epub 2023 Aug 31.
10
New Insights into the Crosstalk among the Interferon and Inflammatory Signaling Pathways in Response to Viral Infections: Defense or Homeostasis.
Viruses. 2022 Dec 15;14(12):2798. doi: 10.3390/v14122798.
本文引用的文献
1
Dysregulation of protein modification by ISG15 results in brain cell injury.
Genes Dev. 2002 Sep 1;16(17):2207-12. doi: 10.1101/gad.1010202.
2
Identification of a nuclear Stat1 protein tyrosine phosphatase.
Mol Cell Biol. 2002 Aug;22(16):5662-8. doi: 10.1128/MCB.22.16.5662-5668.2002.
3
Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.
Cell. 2002 Apr;109 Suppl:S121-31. doi: 10.1016/s0092-8674(02)00701-8.
4
Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3.
J Biol Chem. 2002 Apr 26;277(17):14703-11. doi: 10.1074/jbc.M111527200. Epub 2002 Feb 19.
5
UBP43 (USP18) specifically removes ISG15 from conjugated proteins.
J Biol Chem. 2002 Mar 22;277(12):9976-81. doi: 10.1074/jbc.M109078200. Epub 2002 Jan 11.
6
Ubiquitin enters the new millennium.
Mol Cell. 2001 Sep;8(3):499-504. doi: 10.1016/s1097-2765(01)00347-1.
7
A new ticket for entry into budding vesicles-ubiquitin.
Cell. 2001 Sep 7;106(5):527-30. doi: 10.1016/s0092-8674(01)00485-8.
8
Negative regulation of cytokine signaling.
J Leukoc Biol. 2001 Sep;70(3):348-56.
9
Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH.
Gene. 2001 Apr 18;267(2):233-42. doi: 10.1016/s0378-1119(01)00384-5.
10
Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition.
J Biol Chem. 2001 May 25;276(21):18579-90. doi: 10.1074/jbc.M100846200. Epub 2001 Feb 21.
Zotero 插件